- Home
- POOL vs BMRN Comparison
POOL vs BMRN Comparison
Compare POOL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- BMRN
- Stock Information
- Founded
- POOL 1993
- BMRN 1996
- Country
- POOL United States
- BMRN United States
- Employees
- POOL N/A
- BMRN N/A
- Industry
- POOL Industrial Specialties
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- POOL Consumer Discretionary
- BMRN Health Care
- Exchange
- POOL Nasdaq
- BMRN Nasdaq
- Market Cap
- POOL 11.6B
- BMRN 11.1B
- IPO Year
- POOL 1995
- BMRN 1999
- Fundamental
- Price
- POOL $301.64
- BMRN $54.71
- Analyst Decision
- POOL Hold
- BMRN Buy
- Analyst Count
- POOL 9
- BMRN 20
- Target Price
- POOL $346.43
- BMRN $92.21
- AVG Volume (30 Days)
- POOL 502.2K
- BMRN 2.1M
- Earning Date
- POOL 10-23-2025
- BMRN 10-28-2025
- Dividend Yield
- POOL 1.66%
- BMRN N/A
- EPS Growth
- POOL N/A
- BMRN 154.69
- EPS
- POOL 10.81
- BMRN 3.40
- Revenue
- POOL $5,276,415,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- POOL $1.98
- BMRN $13.35
- Revenue Next Year
- POOL $3.67
- BMRN $9.18
- P/E Ratio
- POOL $27.91
- BMRN $16.10
- Revenue Growth
- POOL N/A
- BMRN 18.36
- 52 Week Low
- POOL $282.22
- BMRN $52.48
- 52 Week High
- POOL $395.60
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- POOL 36.89
- BMRN 45.78
- Support Level
- POOL $306.72
- BMRN $53.19
- Resistance Level
- POOL $313.71
- BMRN $56.26
- Average True Range (ATR)
- POOL 5.57
- BMRN 1.17
- MACD
- POOL -1.62
- BMRN 0.23
- Stochastic Oscillator
- POOL 2.85
- BMRN 51.85
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.